Flexibility of alternative trial designs crucial for cell and gene therapy research
On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.
On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.
Sipavibart demonstrated to offer a statistically significant decline in the symptomatic Covid-19 occurrence.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Allucent receives grant for decentralised Covid-19 vaccine trial
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
MMI pioneers Symani Surgical System in first US cases
“Defensibility” key for AI-centric small biotechs seeking investment